Joseph Vazzano Net Worth & Insider Trades

Joseph Vazzano - Chief Financial Officer, Avenue Therapeutics, Inc

As of December 20, 2021

What is Joseph Vazzano's Net Worth?

The current estimated net worth of Avenue Therapeutics, Inc's Chief Financial Officer, Joseph Vazzano, is estimated to be about $672.22K . Joseph Vazzano owns about 65,252 units of Avenue Therapeutics, Inc common stock. In the last 3 years at Avenue Therapeutics, Inc, Joseph Vazzano has sold an estimated value of $84.38K worth.

What is Joseph Vazzano's Past Insider Trading?

Joseph Vazzano's largest purchase order was 3,389 units , worth over $26.98K on March 10, 2020. Joseph Vazzano's largest sale order was 3,840 units , worth over $46.58K on August 21, 2020. In total, Joseph Vazzano has made about 10 transactions over 3 years of their time at Avenue Therapeutics, Inc. Joseph Vazzano usually trades in August, with the busiest year in 2020. The most recent transaction was a sale order of 7,160 units , worth over $11.6K on September 15, 2021.

Joseph Vazzano

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Joseph Vazzano's Salary in 2019?

As Chief Financial Officer of Avenue Therapeutics, Inc, Joseph Vazzano has a total base salary of $198,113 . Joseph Vazzano received compensation valued at about $258,779 in 2019 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of other earnings, plans or compensations of $50,000 , and other compensation of $10,666 .

What is Joseph Vazzano's' Mailing Address?

  • Mailing address is 2 Gansevoort Street, 9th Floor New York NY 10014 NY

Avenue Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Lucy Lu 2019 $419,055 - - $209,528 $11,200 $639,783
Lucy Lu 2018 $406,850 - $865,000 $315,309 $7,474 $1,594,633
Joseph Vazzano 2019 $198,113 - - $50,000 $10,666 $258,779
Joseph Vazzano 2018 $175,100 - $103,800 $67,851 $7,777 $354,528
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1644963/000110465920052889/tm2016453-1_def14a.htm

What are Avenue Therapeutics, Inc's Past Insider Trades?

Avenue Therapeutics, Inc's most recent insider trade came on October 13, 2022 by Invagen Pharmaceuticals Inc who sold 388,888 units worth $3M . In the last 5 years, insiders at Avenue Therapeutics, Inc have sold an estimated value of $3.08M and bought an estimated value of $662.86K worth of shares. Insider trading is most common in August, with the busiest year in 2018. The most active traders at the company are Neil Herskowitz, Director,  Joseph Vazzano, Chief Financial Officer,  and Lu Lu, President .

AVENUE THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1